Abstract Objective Evidence on the impact of GLP-1 RAs on HF hospitalization (HHF) and mortality has been inconsistent across clinical trials in patients with diabetes
Although the existing evidence in HFpEF is compelling, further trials seem warranted, particularly with respect to the effects of GLP-1 RAs on clinical outcomes and, possibly, in broader patient populations, such as patients with HFrEF or those without obesity.
Some combinations may require modified application schedules or concentrations
There are various types, including osmotic laxatives (e.g., polyethylene glycol) and stimulant laxatives (e.g., senna)
High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence
Inhibition of protein arginine methyltransferase 5 suppresses GPX4 methylation, reduces GPX4 levels, and increases sensitivity to ferroptosis inducers [42]